Latest from Medicines and Healthcare products Regulatory ... | 合法藥品大搜索
15July2021·Corporatereport·MHRA,CHMandBritishPharmacopoeiaCommission.
Topic All topicsBrexitBusiness and industryCOVID-19Corporate informationCrime, justice and lawDefence and armed forcesEducation, training and skillsEntering and staying in the UKEnvironmentGoing and being abroadGovernmentHealth and social careHousing, local and communityInternationalLife circumstancesMoneyParenting, childcare and childrens services Regional and local governmentSociety and cultureTransportWelfareWork
Subtopic All subtopicsBrexit: business guidanceBrexit: guidance for individualsBusiness and the environmentBusiness regulationCharities and social enterprisesCorporate governanceFinancial servicesIndustrial strategyManufacturingMedia and communicationsRunning a businessScience and innovationTrade and investmentUK economyDriving and transport in the UK during COVID-19Education, universities and childcare during COVID-19Health and wellbeing during COVID-19Healthcare workers, carers and care settings during COVID-...
Medicines and Healthcare products Regulatory Agency | 合法藥品大搜索
Welcome to our new MHRA website | 合法藥品大搜索
Services and information | 合法藥品大搜索
About us | 合法藥品大搜索
MHRA guidance on coronavirus (COVID | 合法藥品大搜索
New guidance and information for industry from the MHRA ... | 合法藥品大搜索
Latest from Medicines and Healthcare products Regulatory ... | 合法藥品大搜索
Medicines and Healthcare products Regulatory Agency ... | 合法藥品大搜索
MHRA Products | 合法藥品大搜索
MHRA:MHRA是英國葯監機構的簡稱,全稱為Medicines and ... | 合法藥品大搜索
【樂拿舒注射劑】急性白血病(包括由慢性白血病轉變成急性者)惡性淋巴腫
藥品名稱:樂拿舒注射劑許可證字號:衛署藥輸字第018780號許可證種類:製 劑適應症:急性白血病(包括由慢性白血病轉變成急性者...
【樂拿舒注射劑 10,000 K.U.】急性白血病(包括由慢性白血病轉變成急性者)惡性淋巴腫。
藥品名稱:樂拿舒注射劑10,000K.U.許可證字號:衛署藥輸字第021032號許可證種類:製 劑適應症:急性白血病(包括由慢性白血病轉...